AngioDynamics
Quarterly Financials
| Values in thousands | 2026-08-31 | 2026-05-31 | 2026-02-28 | 2025-11-30 |
|---|---|---|---|---|
Revenue | $80,915 | $86,607 | $78,423 | $79,433 |
Gross Profit | 48,040 | 49,416 | 41,479 | 42,140 |
EBITDA | 377 | -5,333 | -2,393 | -436 |
EBIT | -5,121 | -10,930 | -7,984 | -6,253 |
Net Income | -7,097 | -11,405 | -8,084 | -6,350 |
Net Change In Cash | 80,915 | 86,607 | 78,423 | 79,433 |
Free Cash Flow | -15,709 | 17,039 | -4,125 | 4,239 |
Cash | 33,973 | 53,864 | 37,810 | 41,638 |
Basic Shares | 42,022 | 41,526 | 41,596 | 41,404 |
Annual Financials
| Values in thousands | 2026-05-31 | 2025-05-31 | 2024-05-31 | 2023-05-31 |
|---|---|---|---|---|
Revenue | $320,174 | $292,498 | $303,914 | $338,752 |
Gross Profit | 174,892 | 157,705 | 154,698 | 174,246 |
EBITDA | 488 | 1,738 | -6,132 | 12,194 |
EBIT | -22,467 | -24,062 | -33,844 | -18,679 |
Net Income | -36,742 | -33,993 | -184,349 | -52,442 |
Net Change In Cash | 320,174 | 292,498 | 303,914 | 338,752 |
Cost of Revenue | 15,752 | |||
Free Cash Flow | 508 | -14,592 | -33,926 | -4,274 |
Cash | 53,864 | 55,893 | 76,056 | 44,620 |
Basic Shares | 41,526 | 40,984 | 40,180 | 39,480 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-08-31 | -$0.04 |
2026-05-31 | -$0.07 |
2026-02-28 | $0.02 |
2025-11-30 | -$0.15 |